 | Albireo Pharma Inc (NASDAQ:ALBO) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 6 at 2:52 AM |
| Albireo Pharma Inc (NASDAQ:ALBO) Expected to Post Quarterly Sales of $1.36 Million
www.americanbankingnews.com - May 30 at 3:18 AM |
| Brokerages Expect Albireo Pharma Inc (NASDAQ:ALBO) to Announce -$1.66 Earnings Per Share
www.americanbankingnews.com - May 28 at 2:27 PM |
 | BRIEF-Albireo Pharma Says May Offer, Sell Shares Of Common Stock Having Aggregate Offering Price Of Up To $50 Million
www.reuters.com - May 27 at 11:07 PM |
 | Albireo to Present at 2020 Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 26 at 9:34 AM |
 | ALBO Albireo Pharma, Inc. Common Stock
www.nasdaq.com - May 21 at 11:49 PM |
| Albireo Pharma Inc to Post Q2 2020 Earnings of ($1.51) Per Share, Wedbush Forecasts (NASDAQ:ALBO)
www.americanbankingnews.com - May 14 at 1:55 PM |
| FY2023 Earnings Estimate for Albireo Pharma Inc (NASDAQ:ALBO) Issued By Wedbush
www.americanbankingnews.com - May 13 at 12:32 PM |
| The Consensus EPS Estimates For Albireo Pharma, Inc. (NASDAQ:ALBO) Just Fell Dramatically
finance.yahoo.com - May 12 at 8:44 AM |
| Albireo Pharma, Inc. (NASDAQ:ALBO) Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - May 11 at 7:26 AM |
|
 | Albireo Pharma, Inc.'s (ALBO) CEO Ron Cooper on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 8:43 AM |
| Albireo Pharma EPS misses by $0.87, beats on revenue
seekingalpha.com - May 7 at 12:15 PM |
| Albireo Reports Q1 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 7 at 12:15 PM |
| Recap: Albireo Pharma Q1 Earnings
finance.yahoo.com - May 7 at 12:15 PM |
| How Does Albireo Pharma, Inc. (NASDAQ:ALBO) Affect Your Portfolio Volatility?
finance.yahoo.com - May 3 at 4:32 PM |
| Albireo to Report First Quarter 2020 Financial Results on May 7
finance.yahoo.com - April 30 at 5:54 PM |
 | Albireo Pharma Inc.
www.barrons.com - April 18 at 11:37 PM |
| Albireo to Present at 19th Annual Needham Healthcare Conference
finance.yahoo.com - April 7 at 3:46 PM |
| Albireo advancing mid-stage study of IBAT inhibitor in NASH/NAFLD
seekingalpha.com - March 10 at 1:00 PM |
| Albireo Completes Enrollment in Phase 2 Study of Elobixibat in NASH/NAFLD
finance.yahoo.com - March 10 at 1:00 PM |
| Albireo Pharma, Inc. Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - March 4 at 12:33 PM |
| Albireo Pharma, Inc. (ALBO) Q4 2019 Earnings Call Transcript
www.nasdaq.com - March 2 at 7:31 PM |
| Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 2 at 7:31 PM |
| Albireo Pharma EPS beats by $1.02, beats on revenue
seekingalpha.com - March 2 at 9:31 AM |
| Albireo Reports Fourth Quarter and Year-End 2019 Financial Results, and Provides Business Update
finance.yahoo.com - March 2 at 9:31 AM |
| Albireo Recognizes Rare Disease Day and Supports Global Effort to “Reframe Rare” By Highlighting the Challenges of Cholestatic Liver Disorders
finance.yahoo.com - February 27 at 12:35 PM |
| Did Changing Sentiment Drive Albireo Pharma's (NASDAQ:ALBO) Share Price Down By 17%?
finance.yahoo.com - February 27 at 12:35 PM |
| Albireo to Report Fourth Quarter and Year-End 2019 Financial Results on March 2
finance.yahoo.com - February 24 at 1:02 PM |
| Albireo Pharma: View Ahead Of Phase 3 Data In Progressive Familial Intrahepatic Cholestasis In Mid-2020
seekingalpha.com - February 11 at 7:29 AM |
 | Albireo Announces Closing of $46 Million Public Offering Including Exercise in Full of Underwriters' Option to Purchase Additional Shares
www.marketwatch.com - February 3 at 7:04 PM |
|
| Albireo Announces Closing of $46 Million Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 3 at 7:04 PM |
| Albireo down 11% premarket after pricing equity offering
seekingalpha.com - January 30 at 7:33 AM |
| Albireo Prices $40 Million Public Offering of Common Stock
finance.yahoo.com - January 30 at 12:34 AM |
| Albireo lower after proposing stock offering
seekingalpha.com - January 29 at 7:34 PM |
| Albireo Achieves Significant Milestones for Odevixibat Across Multiple Diseases
finance.yahoo.com - January 29 at 7:34 PM |
| Albireo Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 29 at 7:34 PM |
| Albireo Joins with Alagille Syndrome Community in Celebrating First International Awareness Day
finance.yahoo.com - January 23 at 8:29 AM |
| Do Hedge Funds Love Albireo Pharma, Inc. (ALBO)?
finance.yahoo.com - December 19 at 11:43 PM |
| Is Albireo Pharma, Inc.'s (NASDAQ:ALBO) CEO Salary Justified?
finance.yahoo.com - December 17 at 8:56 AM |
| Albireo to Present at the Jefferies 2019 London Healthcare Conference
finance.yahoo.com - November 14 at 4:26 PM |
| Albireo Pharma, Inc. (ALBO) Q3 2019 Earnings Call Transcript
www.nasdaq.com - November 6 at 10:57 PM |
| Were Hedge Funds Right About Souring On Albireo Pharma, Inc. (ALBO)?
finance.yahoo.com - November 6 at 5:56 PM |
| Albireo Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 6 at 12:52 PM |
| Albireo Appoints Michelle Graham as Chief Human Resources Officer
finance.yahoo.com - November 4 at 8:42 AM |
| Will Albireo Pharma (NASDAQ:ALBO) Spend Its Cash Wisely?
finance.yahoo.com - November 2 at 12:27 PM |
 | Albireo to Report Third Quarter 2019 Financial...
www.benzinga.com - October 30 at 11:03 AM |
| Albireo to Report Third Quarter 2019 Financial Results on November 6, 2019
finance.yahoo.com - October 30 at 11:03 AM |
| Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepatic Cholestasis Families
finance.yahoo.com - October 3 at 9:27 AM |
| Is Albireo Pharma, Inc. (NASDAQ:ALBO) A Volatile Stock?
finance.yahoo.com - September 19 at 9:15 PM |
| Albireo to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 3 at 10:33 AM |
